Search for: "MYLAN, INC." Results 601 - 620 of 674
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jul 2010, 8:15 pm
Mylan Labs., Inc., 464 F.3d 1286, 1289 (Fed. [read post]
6 Aug 2011, 2:27 pm by Law Lady
.'s policy with Warren Funeral Chapel Inc. covered emotional distress under its definition of bodily injury. [read post]
2 Sep 2009, 11:22 pm
Mylan Laboratories, Inc., 2008 WL 4813311, at *6-7 (D. [read post]
24 Mar 2011, 12:53 pm by Christa Culver
Note: Goldstein, Howe & Russell, P.C. serves as counsel to the petitioners in the following case, which is listed without regard to its likelihood of being granted.Title: Kaiser Eagle Mountain, Inc. v. [read post]
1 Sep 2009, 4:39 am
In April, 2008, the FDA announced a recall of the drug Digitek® (Digoxin) distributed by Mylan Bertek Pharmaceuticals, Inc. and UDL Laboratories, Inc. [read post]
4 Sep 2019, 7:17 am by Overhauser Law Offices, LLC
FASHION. 5842251 INDIANA DRUG ENFORCEMENT ASSOCIATION IDEA 5846432 PREVENTIA 5842222 MIER PRODUCTS, INC. 5847208 COMMERCIAL DASHBOARD 5846406 TRIUMPH 5846302 THE SIMPLE 9 5841996 ACACIA 5845875 ACTIVEARTH 5840833 BLUEHIVE 5837486 INTELLIGLOBE 5840762 K KOCOLENE INVESTMENTS 5837402 FATBOY 5837397 SPECOIL 5840623 PAI 5841364 PLAYER ATHLETIC INDEX 5841358 BAND ACADEMY 5837297 RAGGS 5840500 FOUNDATION FOR FRATERNAL EXCELLENCE 5840479 VINDICATE 5840463 COMMITTED TO THE JOURNEY OF MAKING LIVES… [read post]
15 Dec 2010, 2:17 am by Kelly
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not… [read post]
27 May 2011, 8:56 am by Kali Borkoski
Cir.)Petition for certiorariBrief in oppositionPetitioner's reply10-627Title: Extreme Networks, Inc. v. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
11 Jun 2007, 10:15 pm
Mylan Labs., Inc., 464 F.3d 1286 (2006)) applied a more flexible obviousness test and may be consistent with the Supreme Court’s view set forth in KSR. [read post]
5 Aug 2010, 6:00 am by Lucas A. Ferrara, Esq.
The investigation is being conducted by Assistant Attorney General Carol Hunt of the Health Care Bureau under the supervision of Executive Deputy Attorney General for Social Justice Mylan Denerstein and Special Counsel to the Attorney General Linda A. [read post]